BPGAM
IPXL

BTG Pactual Global Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

BTG Pactual Global Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,251
Closed -$267K – 256
2014
Q3 		$267K Buy
+11,251
New +$288K 0.03% 183

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BTG Pactual Global Asset Management's IPXL Position: Q4 2014 in Review

BTG Pactual Global Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2014, closing a stake of 11,251 shares — an estimated $267K sold.

BTG Pactual Global Asset Management first reported a position in IPXL in Q3 2014 and held it in 1 quarter. The position peaked at $267K in Q3 2014. 178 funds tracked by Wall St. Rank hold IPXL as of Q4 2014.

  • BTG Pactual Global Asset Management reported no remaining Impax Laboratories, Inc. position as of Q4 2014 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 11,251 Impax Laboratories, Inc. shares in Q4 2014, an estimated $267K.
  • BTG Pactual Global Asset Management first reported a position in Impax Laboratories, Inc. in Q3 2014 and held it in 1 quarter.
  • BTG Pactual Global Asset Management's Impax Laboratories, Inc. position peaked at $267K in Q3 2014.
  • 178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2014.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.